| 調查批次:CHT2015-04 | 檢體寄出日期:2015-04-27 | 報告回收截止日期:2015-05-04 | 回收份數:21 | 
| TSH 檢驗院際品管調查結果: | ||
| 2.歷次品管檢體 TSH 檢驗值之實驗室間 CV 分佈圖 | ||
| 4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 | 
| 檢驗單位 <代碼> | 確診醫院 <代碼> | 
          回報 天數 | 檢體  S1  | 檢體 S2  | ||||||||||||
| ( mIU/L ) | D | D% | z | SDI | Da% | ( mIU/L ) | D | D% | z | SDI | Da% | |||||
| RH01b | RH01 | 2 | 1 | 3 | 21.8 | 6.2 | 39.7 | 5.0 | 1.1 | 165 | 6.5 | 1.6 | 32.7 | 4.1 | 0.5 | 137 | 
| RH07b | RH07 | 7 | 1 | 3 | 19.8 | 4.2 | 26.9 | 3.4 | -0.4 | 112 | 6.3 | 1.4 | 28.6 | 3.6 | 0.0 | 120 | 
| RH14 | RH14 | 4 | 1 | 3 | 18.3 | 2.7 | 17.3 | 2.2 | -1.4 | 72 | 6.3 | 1.4 | 28.6 | 3.6 | 0.0 | 120 | 
| RH15 | RH15 | 7 | 1 | 3 | 20.0 | 4.4 | 28.2 | 3.5 | -0.2 | 117 | 6.5 | 1.6 | 32.7 | 4.1 | 0.5 | 137 | 
| CL009 | CL009 | 7 | 1 | 3 | 20.9 | 5.3 | 34.0 | 4.2 | 0.4 | 141 | 6.4 | 1.5 | 30.6 | 3.8 | 0.3 | 128 | 
| CL010 | CL010 | 3 | 1 | 3 | 22.0 | 6.4 | 41.0 | 5.1 | 1.2 | 171 | 6.3 | 1.4 | 28.6 | 3.6 | 0.0 | 120 | 
| CL012 | CL012 | 7 | 1 | 3 | 20.2 | 4.6 | 29.5 | 3.7 | -0.1 | 123 | 6.3 | 1.4 | 28.6 | 3.6 | 0.0 | 120 | 
| CL013 | CL013 | 3 | 1 | 5 | 21.2 | 5.6 | 35.9 | 4.5 | 0.6 | 149 | 5.7 | 0.8 | 16.3 | 2.1 | -1.5 | 68 | 
| CL014a | CL014 | 7 | 1 | 3 | 18.6 | 3.0 | 19.2 | 2.4 | -1.2 | 80 | 5.6 | 0.7 | 14.3 | 1.8 | -1.8 | 60 | 
| CL015 | CL015 | 7 | 1 | 3 | 20.5 | 4.9 | 31.4 | 3.9 | 0.1 | 131 | 6.8 | 1.9 | 38.8 | 4.9 | 1.3 | 162 | 
| Median of RIA Group | 20.4  | 6.3 | ||||||||||||||
| Range of RIA Group | 18.3 - 22.0 | 5.6 - 6.8 | ||||||||||||||
| Robust mean of RIA Group | 20.3 ( n = 10 ) | 6.3 ( n = 10 ) | ||||||||||||||
| Robust SD of RIA Group | 1.39 | 0.39 | ||||||||||||||
| CV of RIA Group | 6.8% | 6.2% | ||||||||||||||
| Median of European RIA Labs | 15.8 ( n = 106 ) | 5.2 ( n = 104 ) | ||||||||||||||
| Range of European RIA Labs ( 16% - 84% ) | 14.8 - 20.7 | 4.6 - 6.6 | ||||||||||||||
| 檢驗單位 <代碼> | 確診醫院 <代碼> | 回報 天數 | 檢體  S1  | 檢體 S2  | ||||||||||||
| ( mIU/L ) | D  | D% | z | SDI | Da% | ( mIU/L ) | D | D% | z | SDI | Da% | |||||
| RH01a | RH01 | 2 | 3 | 9 | 15.4 | -0.2 | -1.3 | -0.2 | 0.4 | -5 | 4.9 | 0.0 | 0.0 | 0.0 | 0.6 | 0 | 
| RH02c | RH02 | 7 | 3 | 1 | 12.1 | -3.5 | -22.4 | -2.8 | -2.5 | -93 | 3.8 | -1.1 | -22.4 | -2.8 | -1.6 | -94 | 
| RH06 | RH06 | 2 | 3 | 9 | 15.6 | 0.0 | 0.0 | 0.0 | 0.6 | 0 | 5.0 | 0.1 | 2.0 | 0.3 | 0.8 | 9 | 
| RH07a | RH07 | 2 | 3 | 2 | 14.8 | -0.8 | -5.1 | -0.6 | -0.1 | -21 | 4.4 | -0.5 | -10.2 | -1.3 | -0.4 | -43 | 
| RH12 | RH12 | 2 | 3 | 2 | 15.8 | 0.2 | 1.3 | 0.2 | 0.8 | 5 | 4.9 | 0.0 | 0.0 | 0.0 | 0.6 | 0 | 
| RH19 | RH19 | 5 | 3 | 2 | 14.8 | -0.8 | -5.1 | -0.6 | -0.1 | -21 | 4.8 | -0.1 | -2.0 | -0.3 | 0.4 | -9 | 
| RH20 | RH20 | 2 | 3 | 7 | 14.3 | -1.3 | -8.3 | -1.0 | -0.5 | -35 | 4.3 | -0.6 | -12.2 | -1.5 | -0.6 | -51 | 
| CL005 | CL005 | 3 | 3 | 9 | 14.6 | -1.0 | -6.4 | -0.8 | -0.3 | -27 | 4.8 | -0.1 | -2.0 | -0.3 | 0.4 | -9 | 
| CL006a | CL006 | 3 | 3 | 7 | 13.5 | -2.1 | -13.5 | -1.7 | -1.3 | -56 | 4.1 | -0.8 | -16.3 | -2.1 | -1.0 | -68 | 
| CL008 | CL008 | 4 | 3 | 2 | 15.3 | -0.3 | -1.9 | -0.2 | 0.4 | -8 | 4.5 | -0.4 | -8.2 | -1.0 | -0.2 | -34 | 
| CL011 | CL011 | 0 | 3 | 13 | 16.9 | 1.3 | 8.3 | 1.0 | 1.8 | 35 | 5.4 | 0.5 | 10.2 | 1.3 | 1.6 | 43 | 
| Median of CLIA Group | 14.8 | 4.8 | ||||||||||||||
| Range of CLIA Group | 12.1 - 16.9 | 3.8 - 5.4 | ||||||||||||||
| Robust mean of CLIA Group | 14.9 ( n = 11 ) | 4.6 ( n = 11 ) | ||||||||||||||
| Robust SD of CLIA Group | 1.12 | 0.49 | ||||||||||||||
| CV of CLIA Group | 7.5% | 10.7% | ||||||||||||||
| Median of European CLIA Labs | 15.6 ( n = 1203 ) | 4.9 ( n = 1221 ) | ||||||||||||||
| Range of European CLIA Labs ( 16% - 84% ) | 13.0 - 16.7 | 4.2 - 5.2 | ||||||||||||||
| Median of All Labs | 16.9 | 5.4 | ||||||||||||||
| Range of All Labs | 12.1 - 22.0 | 3.8 - 6.8 | ||||||||||||||
| Robust mean of All Labs | 17.5 ( n = 21 ) | 5.4 ( n = 21 ) | ||||||||||||||
| Robust SD of All Labs | 3.46 | 1.05 | ||||||||||||||
| CV of All Labs | 19.8% | 19.4% | ||||||||||||||
| Median of All European Labs ( Xa ) | 15.6 | 4.9 | ||||||||||||||
| Range of All European Labs ( 16% - 84% ) | 13.1 - 16.9 | 4.2 - 5.3 | ||||||||||||||
| Mean of All European Labs  | 15.4 ( n = 1430 ) | 4.9 ( n = 1429 ) | ||||||||||||||
| SD of All European Labs | 2.06 | 0.59 | ||||||||||||||
| CV of All European Labs | 13.4% | 12.2% | ||||||||||||||
| SD for proficiency
assessment ( σp ) | 1.248  | 0.39  | ||||||||||||||
| 
 | ||||||||||||||||
| Method Code
             | Laboratory | |
|  Radioimmunoassay ( Sandwich-type )  | 1 | 
			RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL014a, CL015,              | 
| Chemiluminescent Immunoassay ( Sandwich-type ) | 3 | RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011,  | 
| Reagent Code | Laboratory | |
| Abbott Architect  | 1  | RH02c,  | 
| Beckman Coulter Access  | 2  | RH07a, RH12, RH19, CL008,  | 
| Cisbio RIA-gnost  | 3  | RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL014a, CL015,  | 
| Immunotech  | 5  | CL013,  | 
| Siemens ADVIA Centaur  | 7  | RH20, CL006a,  | 
| Siemens Immulite 2000  | 9  | RH01a, RH06, CL005,  | 
| Roche | 13  | CL011,  | 
若有任何疑問,歡迎來電(函)聯繫或指教
 財團法人預防醫學基金會
 
  財團法人預防醫學基金會 
  
   地 址:10699 台北郵政 26-624 號信箱  電 話:(02) 
  2703-6080
 
  地 址:10699 台北郵政 26-624 號信箱  電 話:(02) 
  2703-6080
      e-mail: 傳 真: (02) 
  2703-6070
 
    傳 真: (02) 
  2703-6070
  
        
  
            updated 
  :   2015-05-06